Workplace Intervention: Activity Monitoring as a Tool for Corporate Wellness and Weight Loss
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01461382|
Recruitment Status : Completed
First Posted : October 28, 2011
Last Update Posted : October 28, 2011
Is a one-year intervention with Treadmill Desks associated with increased employee daily physical activity and decreased sedentariness.
36 employees with sedentary jobs (87 + 27 kg, BMI 29 + 7 kg/m2) used a Treadmill Desk for one year. Daily Physical Activity, work performance, body composition, and blood variables were measured at Baseline and 6 and 12 months after the Treadmill Desk intervention.
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Other: Treadmill Desks||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||36 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Workplace Intervention: Activity Monitoring as a Tool for Corporate Wellness and Weight Loss|
|Study Start Date :||May 2008|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||December 2009|
Experimental: Phase I
Entered Study May 2008.
Other: Treadmill Desks
Treadmill Desk were installed in subjects personal workspace.
Experimental: Phase II
Phase II entered 6 months after Phase I. Phase II was a no intervention control for 6 months, then followed an identical intervention protocol to Phase I.
Other: Treadmill Desks
Treadmill desks were installed in subjects personal workspace six months after phase I started.
- Daily Physical Activity [ Time Frame: 1 year ]Measured for all waking hours using tri-axial accelerometry.
- Body Weight [ Time Frame: baseline, 6 months, 12 months ]
- Body Composition [ Time Frame: baseline, 6 months, 12 months ]
- Venous blood [ Time Frame: baseline, 6 months, 12 months ]
- Work performance [ Time Frame: baseline, 6 months, 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01461382
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||James A Levine, MD PhD||Mayo Clinic|